{
    "clinical_study": {
        "@rank": "53814", 
        "acronym": "MISSION", 
        "arm_group": [
            {
                "arm_group_label": "PDM-SuperSTAT", 
                "arm_group_type": "Other", 
                "description": "PDM-SuperSTAT Arm (minimum of 55 evaluable patients): GE DINAMAP\u00ae SuperSTAT algorithm delivered by the PDM acquisition module connected to the CARESCAPE Monitor B650"
            }, 
            {
                "arm_group_label": "PSM-Datex-Ohmeda", 
                "arm_group_type": "Other", 
                "description": "PSM-Datex-Ohmeda Arm (minimum of 45 evaluable patients): Datex-Ohmeda delivered by the PSM acquisition module connected to the CARESCAPE Monitor B650"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is required to demonstrate that the non-invasive blood pressure (NIBP)\n      measurement algorithms on two commercially available devices provide accurate NIBP\n      measurements in accordance with the guidelines provided by the most recent International\n      Organization for Standardization (ISO) 81060-2:2013 requirements relevant to Unites States\n      devices and the BS EN 1060-4:2004 standard widely recognized in Europe. This study will\n      assess neonate, infant, children, pediatric, adolescent, and adult patients as well as\n      adults with chronic atrial fibrillation in a population that requires non-emergent heart\n      catheterization. This is a study conducted to satisfy both standards for two NIBP devices\n      and, as such, does not require a statistical hypothesis."
        }, 
        "brief_title": "Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Blood Pressure", 
        "detailed_description": {
            "textblock": "This study is required to demonstrate that the non-invasive blood pressure (NIBP)\n      measurement algorithms on two commercially available multifunction hemodynamic acquisition\n      modules, the Patient Data Module (PDM) equipped with the DINAMAP\u00ae SUPERSTAT algorithm\n      (\"PDM-SUPERSTAT\") and the Patient Side Module (PSM) equipped with Datex-Ohmeda GE algorithm\n      (\"PSM-Datex-Ohmeda\"), provide accurate NIBP measurements in accordance with the guidelines\n      provided by the most recent International Organization for Standardization (ISO)\n      81060-2:2013 requirements relevant to Unites States devices and the BS EN 1060-4:2004\n      standard widely recognized in Europe.\n\n      Notably, the new ISO 81060-2:2013 supersedes the previous 2009 version of this standard, and\n      this study is being conducted in accordance with the most recent applicable standards.\n\n      This study will assess neonate, infant, children, pediatric, adolescent, and adult patients\n      as well as adults with chronic atrial fibrillation in a population that requires\n      non-emergent heart catheterization."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Require non-emergent heart catheterization (all subjects except neonates);\n\n          -  Neonates only - umbilical arterial lines that have been placed for route care.\n\n          -  Have an upper limb (right OR left side) that fits a cuff size of the device\n             (circumference ranging 3 cm to 40 cm) OR have a thigh (right OR left side) that fits\n             a cuff size of the device (circumference ranging 38 to 50 cm);\n\n          -  Is willing and able to provide blood pressure measurements using both IBP and NIBP;\n\n          -  Is able and willing to provide written informed consent or has a legally authorized\n             representative that is willing to provide written informed consent\n\n          -  If informed consent is provided by a legally authorized representative on the\n             patient's behalf, the subject is willing to provide assent to study participation, if\n             capable of providing assent in the opinion of the investigator.\n\n        Exclusion Criteria:\n\n          -  Do not meet the stratification quota set forth in Tables 1 and 2 in the protocol;\n\n          -  Exhibit signs or symptoms or have a current diagnosis of peripheral vascular disease\n             in either upper AND/OR lower limbs;\n\n          -  Have current, uncontrolled circulatory shock;\n\n          -  Exhibit injuries, deformities, intravenous lines, or other abnormalities that, in the\n             opinion of the investigator, may prevent proper cuff application or functioning;\n\n          -  Are currently pregnant, suspect that they are pregnant, or are currently lactating;\n\n          -  Have contraindications to standard BP measurements;\n\n          -  Have any other condition that makes the subject unable to tolerate 4 fast flushes\n             (adult, adolescent, or pediatric) or 1 fast flush (neonates and children <3 years of\n             age) for dynamic calibration without posing a risk to the patient's physiological\n             stability"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02125331", 
            "org_study_id": "123.04-2013-GES-0008"
        }, 
        "intervention": {
            "arm_group_label": [
                "PDM-SuperSTAT", 
                "PSM-Datex-Ohmeda"
            ], 
            "description": "3-15 Non-Invasive Blood Pressure readings on the CARESCAPE B650 Patient Monitor equipped with PSM-Datex-Ohmeda and PDM-SuperSTAT NIBP measurement devices during non-emergent heart catheterization", 
            "intervention_name": "Device: Blood pressure monitoring with GE Healthcare CARESCAPE B650 Patient Monitor-Patient Side Module (PSM) or Patient Data Module (PDM)", 
            "intervention_type": "Procedure", 
            "other_name": [
                "GE Healthcare CARESCAPE B650 Patient Monitor", 
                "Patient Side Module with Datex-Ohmeda software algorithm (PSM)", 
                "Patient Data Module with SuperSTAT software algorithm (PDM)"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Blood Pressure", 
        "lastchanged_date": "May 15, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Froedtert Hospital/Medical College of Wisconsin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Children's Hospital of Wisconsin"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Measurement of NonInvasive Blood Pressure With DINAMAP SuperSTAT and Datex-Ohmeda With Intra-arterial Blood Pressure in Neonates Through Adults and Special Populations", 
        "overall_official": [
            {
                "affiliation": "Medical College of Wisconsin", 
                "last_name": "David S Marks, MD, MBA", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Children's Hospital and Health System  Foundation, Wisconsin", 
                "last_name": "Susan Foerster, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Determining the accuracy of non-invasive blood pressure measurement compared to invasive blood pressure. A detailed analysis will be conducted on the invasive blood pressure to verify accuracy as defined in the following standards: BS EN 1060-4:2004 and ISO 81060-2 Second edition 2013-05-01.", 
            "measure": "Accuracy of NIBP Measurement", 
            "safety_issue": "No", 
            "time_frame": "60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125331"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "GE Healthcare", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GE Healthcare", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}